Emboline
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2811 Mission St, Santa Cruz, California,...Phone Number
(831) 900-5020Website
www.emboline.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Emboline
Founded in 2011, headquartered in Santa Cruz, California, Emboline, Inc., is a privately-held, emerging medical device company that has developed the Emboliner Embolic Protection Catheter, a game-changing embolic protection technology for TAVR and other interventional procedures with embolic risks. The novel Emboliner device is intended to more reliably protect the cerebral system, while also capturing non-cerebral debris. Emboline's technologies are derived from intellectual property invented by Amir Belson.Explore more
Emboline Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Emboline your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Emboline, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Emboline has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Emboline recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Emboline
Funding: Get notified immidiatlly once Emboline has new funding data
Click to see if Emboline had a recent Job posting/layoffs
Product Launch: Get notified when Emboline launches new products
Check out if Emboline is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Emboline
Compare insights from companies similar to Emboline, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Emboline is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Emboline is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Emboline.
Emboline financials insights
Gather financial insights about Emboline, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series B
$10M
2020
Other Financing Round
$5M
2021
Series C
$10M
Series D
$55M
Emboline Tech Stack
A closer look at the technologies used by Emboline
Most Recent Scoops
Project
Intellectual Property, Lawsuits, Legal Affairs, Healthcare Technology
Funding
Funding
Funding
Funding
Funding
Funding
Emboline News & Media
Emboline Announces Positive Pivotal PROTECT H2H Trial Results for Emboliner® Presented as a Late-Breaking Clinical Trial at ACC 2026
Randomized IDE study met all primary and secondary safety and efficacy endpoints and demonstrated superior debris capture and significantly higher technical success versus the leading embolic protection control device in TAVR SANTA CRUZ, Calif., March 30, 2026 /PRNewswire/ -- Emboline,...Emboline plots US-EU launch of embolic protection system following $20m fundraise
Emboline expects that its technology designed to reduce stroke risk during structural heart procedures will launch in the US and Europe later this year.Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR
SANTA CRUZ, Calif., March 11, 2026 /PRNewswire/ -- Emboline, Inc., a privately held medical technology company focused on reducing stroke and ischemic damage during structural heart procedures such as transcatheter aortic valve replacement (TAVR), today announced it has closed $20 Million...Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology
PHOENIX, March 11, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity"), a leading international alternative asset manager, today announced the commitment of $20 million in growth capital to Emboline, Inc. ("Emboline"), a MedTech company focused on reducing strokes and...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Emboline
Sign Up For FreeTo access detailed company insights
Founded in 2011, headquartered in Santa Cruz, California, Emboline, Inc., is a privately-held, emerging medical device company that has developed the Emboliner Embolic Protection Catheter, a game-changing embolic protection technology for TAVR and other interventional procedures with embolic risks. The novel Emboliner device is intended to more rel... Read More
